| Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering ME Frohbergh, A Katsman, GP Botta, P Lazarovici, CL Schauer, ... Biomaterials 33 (36), 9167-9178, 2012 | 443 | 2012 |
| The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. M Reichert, AK Rustgi, S Takano, JA von Burstin, S Heeg, GP Botta, ... Cancer Research 72 (14 Supplement), A71-A71, 2012 | 132 | 2012 |
| SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy K Mardinian, JJ Adashek, GP Botta, S Kato, R Kurzrock Molecular cancer therapeutics 20 (12), 2341-2351, 2021 | 115 | 2021 |
| Isolation, culture and genetic manipulation of mouse pancreatic ductal cells M Reichert, S Takano, S Heeg, B Bakir, GP Botta, AK Rustgi Nature protocols 8 (7), 1354-1365, 2013 | 103 | 2013 |
| Tumor-penetrating therapy for β5 integrin-rich pancreas cancer T Hurtado de Mendoza, ES Mose, GP Botta, GB Braun, VR Kotamraju, ... Nature communications 12 (1), 1541, 2021 | 58 | 2021 |
| Constitutive K-RasG12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1 GP Botta, MJ Reginato, M Reichert, AK Rustgi, PI Lelkes Molecular cancer research 10 (2), 183-196, 2012 | 55 | 2012 |
| SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer GP Botta, S Kato, H Patel, P Fanta, S Lee, R Okamura, R Kurzrock JCI insight 6 (18), 2021 | 49 | 2021 |
| Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers BM Huffman, VN Aushev, GL Budde, J Chao, F Dayyani, D Hanna, ... JCO Precision Oncology 6, e2200420, 2022 | 46 | 2022 |
| Real-time assessment of three-dimensional cell aggregation in rotating wall vessel bioreactors in vitro GP Botta, P Manley, S Miller, PI Lelkes Nature protocols 1 (4), 2116-2127, 2006 | 33 | 2006 |
| Phenotype of five cases of prenatally diagnosed campomelic dysplasia harboring novel mutations of the SOX9 gene B Gentilin, F Forzano, MF Bedeschi, T Rizzuti, F Faravelli, C Izzi, ... Ultrasound in Obstetrics and Gynecology 36 (3), 315-323, 2010 | 31 | 2010 |
| ERK2-regulated TIMP1 induces hyperproliferation of K-RasG12D-transformed pancreatic ductal cells GP Botta, M Reichert, MJ Reginato, S Heeg, AK Rustgi, PI Lelkes Neoplasia 15 (4), 359-IN1, 2013 | 28 | 2013 |
| Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome MS Bhangoo, B Cheng, GP Botta, P Thorson, MP Kosty Molecular and Clinical Oncology 8 (4), 609-612, 2018 | 25 | 2018 |
| Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis J Shaya, S Kato, JJ Adashek, H Patel, PT Fanta, GP Botta, JK Sicklick, ... NPJ genomic medicine 8 (1), 1, 2023 | 20 | 2023 |
| Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer. SA Cohen, PM Kasi, VN Aushev, DL Hanna, GP Botta, S Sharif, ... Journal of clinical oncology 41 (4_suppl), 5-5, 2023 | 19 | 2023 |
| Multicenter phase Ib trial in the US of salvage CT041 CLDN18. 2-specific chimeric antigen receptor T-cell therapy for patients with advanced gastric and pancreatic adenocarcinoma. GP Botta, CR Becerra, Z Jin, DW Kim, D Zhao, HJ Lenz, H Ma, A Ween, ... Journal of Clinical Oncology 40 (16_suppl), 2538-2538, 2022 | 18 | 2022 |
| Sex of muscle stem cells does not influence potency for cardiac cell therapy L Drowley, M Okada, TR Payne, GP Botta, H Oshima, BB Keller, K Tobita, ... Cell Transplantation 18 (10-11), 1137-1146, 2009 | 16 | 2009 |
| Advances on immunotherapy in genitourinary and renal cell carcinoma GP Botta, E Granowicz, C Costantini Translational Cancer Research 6 (1), 2017 | 14 | 2017 |
| Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. GP Botta, M Abdelrahim, VN Aushev, A Esmail, B Drummond, S Sharma, ... Journal of Clinical Oncology 40 (4_suppl), 517-517, 2022 | 13 | 2022 |
| Tumor-penetrating therapy for β5 integrin-rich pancreas cancer, Nat. Commun. 12 (2021) 1541 TH De Mendoza, ES Mose, GP Botta, GB Braun, VR Kotamraju, ... | 13 | |
| Challenges and prospects of CSF1R targeting for advanced malignancies A Moeller, R Kurzrock, GP Botta, JJ Adashek, H Patel, S Lee, S Pabla, ... American Journal of Cancer Research 13 (7), 3257, 2023 | 11 | 2023 |
Maximilian ReichertProfessor for Translational Pancreatic Cancer Research, TU MunichZweryfikowany adres z tum.de
